UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000019274
Receipt number R000022287
Scientific Title The analysis of drug-related anaphylactic cases by using PMDA database
Date of disclosure of the study information 2015/10/08
Last modified on 2022/10/17 15:50:13

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The analysis of drug-related anaphylactic cases by using PMDA database

Acronym

Analysis of anaphylactic cases from PMDA database
(PMDA-An analysis)

Scientific Title

The analysis of drug-related anaphylactic cases by using PMDA database

Scientific Title:Acronym

Analysis of anaphylactic cases from PMDA database
(PMDA-An analysis)

Region

Japan


Condition

Condition

Anaphylaxis

Classification by specialty

Clinical immunology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To clarify mainstay drugs and drugs with high mortality rate in drug-related anaphylaxis cases

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

To clarify an outline of drug related anaphylaxis cases in Japan

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Cases that were suspected as adverse reaction of drugs and reported to PMDA

Key exclusion criteria

None

Target sample size

15000


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Motohiro Ebisawa

Organization

National Hospital Organization Sagamihara National Hospital

Division name

Department of Allergy, Clinical Research Center for Allergy and Rheumatology

Zip code


Address

18-1, Sakuradai, Minami-ku, Sagamihara, Kanagawa, Japan, 252-0392

TEL

042-742-8311

Email

mebisawa@foodallergy.jp


Public contact

Name of contact person

1st name
Middle name
Last name Chizuko Sugizaki

Organization

National Hospital Organization Sagamihara National Hospital

Division name

Department of Allergy, Clinical Research Center for Allergy and Rheumatology

Zip code


Address

18-1, Sakuradai, Minami-ku, Sagamihara, Kanagawa, Japan, 252-0392

TEL

042-742-8311

Homepage URL


Email

sugizaki@foodallergy.jp


Sponsor or person

Institute

National Hospital Organization Sagamihara National Hospital

Institute

Department

Personal name



Funding Source

Organization

Japanese Society of Allergology

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

国立病院機構相模原病院(神奈川県)Sagamihara National Hosital


Other administrative information

Date of disclosure of the study information

2015 Year 10 Month 08 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled

16916

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results

2022 Year 05 Month 14 Day

Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2015 Year 04 Month 21 Day

Date of IRB

2015 Year 04 Month 21 Day

Anticipated trial start date

2015 Year 04 Month 21 Day

Last follow-up date

2021 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Study design: retrospective cohort study
Subjects: Cases that were suspected as adverse reaction of drugs and reported to PMDA from April 2004 to February 2018
Analyzing items: Number of cases of each year, therapeutic category, product, route of administration etc.


Management information

Registered date

2015 Year 10 Month 08 Day

Last modified on

2022 Year 10 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022287


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name